Translation. Region: Russian Federation –
Source: Peter the Great St. Petersburg Polytechnic University –
An important disclaimer is at the bottom of this article.
A signing ceremony for a memorandum of strategic partnership with the Russian biotechnology company ARTSELLENS was held at St. Petersburg Polytechnic University. Ilya Bardin-Denisov, CEO of ARTSELLENS LLC, and Yuri Fomin, Vice-Rector for Research at SPbPU, attended the ceremony.
The primary goal of the partnership is the joint development of an advanced technological platform for the creation of RNA-based therapeutics. This platform will enable the rapid development of highly effective drugs against a wide range of socially significant diseases.
The collaboration between the industrial partner and the research center will enable the use of the Polytechnic University's existing facilities not only for development but also for preclinical animal studies, while pilot production will be established at the Technopolis Moscow site. ARTSELLENS will be responsible for bringing the developed drugs to the clinical trial stage, their registration, and subsequent market launch in Russia and the EAEU.
Ilya Bardin-Denisov, CEO of ARTSELLENS, noted: "The signing of this memorandum marks an important step in expanding our portfolio through the use of innovative RNA-based technologies. Synergy with one of the country's leading research centers will enable us to utilize the full scientific and technical potential of this leading research center to develop effective, safe, and, importantly, affordable medications. The use of digital approaches will significantly reduce the time and costs of expensive development stages and preclinical trials, eliminating obviously unsuccessful options. We are investing not just in research, but in the creation of next-generation products."
Ceremony participants agreed that collaboration between business and science facilitates the solution of complex scientific and technological problems, and accelerates the development and availability of innovative medicines for Russian patients.
For our university, this partnership is an opportunity to apply our powerful scientific and technical expertise in biotechnology to address practical national healthcare challenges. The joint project with ARTSELLENS aims to create a fully-fledged national platform that will open up new opportunities for quickly responding to the challenges posed by the emergence of new diseases, added Yuri Fomin, Vice-Rector for Research at SPbPU.
Please note: This information is raw content obtained directly from the source. It represents an accurate account of the source's assertions and does not necessarily reflect the position of MIL-OSI or its clients.